Bladder carcinoma

Disease Term Disease ID Gene Symbol References
Carcinoma of bladder C0699885 ATM
ATP7A
CLK3 25281661
EPHA4
ERBB3
ERCC2
FANCC
FGFR3 25157968, 20542753, 19381019
MTOR
HRAS 25157968
MDM4
NOTCH1
NOTCH2
RB1
SLC14A1 21750109, 21824976, 24163127
TSC1
TTN
KDM6A
PSCA 19648920, 24163127, 20972438
JRK 19648920, 20972438, 24163127
CWC27 27206850
TACC3 20348956, 24163127, 20972438
STAG2
NBEA 31277774
UGT1A10 24163127, 20972438
UGT1A8 24163127, 20972438
RNF43
CDKAL1 24163127
PAG1 24163127
MYNN 24163127
TBL1XR1
PEAK1
CLPTM1L 20972438, 24163127
FMN1 24662972
LINC02871 24163127
CASC11 24163127, 18794855, 24861552, 20348956, 20972438
Carcinoma in situ of bladder C0154091 ATM
ERBB3
ERCC2
FANCC
FGFR3
MTOR
HRAS
MDM4
NOTCH1
NOTCH2
RB1
TSC1
KDM6A
STAG2
TBL1XR1
Transitional cell carcinoma of bladder C0279680 AKT1
APC
BCR
BRAF 26619011
BRCA2
BUB1
BUB1B
CDKN2A 26619011
CREBBP 26619011
CTNNB1 26619011
DCC
EP300 26619011
ERBB2 26619011
ERBB3 26619011
FGFR1 26619011
FGFR3 26619011
FLT1
MTOR 24625776
HRAS 26619011
IDH1 26619011
KRAS 26619011
NFE2L2 26619011
NRAS 26619011
PIK3CA 26619011
MAPK1 26619011
MAP2K1 26619011
PTEN
RB1
RET
RHEB 26619011
RXRA 26619011
SRC
TP53 26619011
U2AF1 26619011
COL14A1
AXIN2
CNOT9 26619011
DLC1
SF3B1 26619011
FBXW7 26619011
AAGAB
FLCN